Skip to content

Comparative clinical study of patolamooladi kashaya and kushtaghna kashaya in the management of ekakushta(psoriasis).

A Clinical Comparative Study Of Patolamooladi Kashaya And Kushtaghna Kashaya In The Management Of Ekakushta(Psoriasis). - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/111232
Enrollment
60
Registered
2026-05-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified

Interventions

None listed

Sponsors

Dr Shivani Ramchandra Waghmare
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Not allergic to any medication. 2)Clinical features of ekakushta- aswedanam, mahavastu, matsyashakalopam, kandu, rukshata, bahalatva, unnti any of these or all.

Exclusion criteria

Exclusion criteria: 1)Pregnant and lactating mother. 2)K/C/O systemic disorders like DM,HTN. 3)If have any acute illness/complication. 4)Patient under cortocosteroid therapy. 5)Patient suffering with tuberculosis and seropositive like HIV,HbSAg. 6)Patient on chemotherapy,radiotherapy. 7)Patient of psoriatic arthritis.

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of patolmaooladi kashaya and kushtaghna kashaya in the management of ekakushta(psoriasis) .Timepoint: 30 days

Secondary

MeasureTime frame
1)To study the effect of patolmooladi kashaya in the management of ekakushta(psoriasis). 2)To study the effect of kushtaghna kashaya in the management of ekakushta(psoriasis).Timepoint: 30 days

Countries

India

Contacts

Public ContactDr Shivani Ramchandra Waghmare

Ashvin Rural Ayurved College And Hospital , Manchi Hill

dr.abhijitgaikwad3184@gmail.com9890101445

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026